Arbios Systems Publishes Positive Results From Completed Sepet Feasibility Clinical Trial

September 7, 2007

Arbios Systems, Inc., a company developing proprietary medical devices and cell-based therapies for the millions of patients each year who experience or are at risk for life-threatening episodes of liver failure, announced positive results from the completed feasibility clinical trial of its SEPET Liver Assist Device, in which 79% of patients met the primary clinical effectiveness endpoint.